Grant: Doctoral: Vanier Canada Graduate Scholarships
McGill University
$150,000.00
Unveiling the Unique Transcriptomic Landscape of Ependymal Cells in Multiple Sclerosis and Neurodegeneration: A Multimodal Study of Cerebrospinal Fluid Dynamics and Periventricular Inflammation
FY 2021-22
Summary
The brain is a complex organ composed of two primary cell types: neurons and glia. Neurons communicate through interfaces called synapses, which allow us to think, feel, and act. Glia are the true workhorses of the brain that support neurons in a variety of roles. The ependymal cell is a unique glial cell that, until recently, has been critically understudied. Ependymal cells line a set of cavities in the center of the brain called ventricles, which contain cerebrospinal fluid (CSF). Recent evidence suggests that ependymal cells are critical in maintaining circulation of CSF and mediating the exchange of nutrients/waste between CSF and surrounding brain tissue. Further, ependymal cell disruption leads to widespread brain degeneration and alterations in the flow of CSF. Interestingly, these patterns of brain dysregulation are strikingly similar to those in the brains of patients with multiple sclerosis (MS), a neurological disease in which aberrant immune cells initiate widespread inflammation in the brain. Despite these similarities, we still do not understand how ependymal cells become damaged or how these alterations might contribute to brain dysfunction in MS. Our lab will use two distinct methods to assess the role of ependymal cells both directly in MS, and more generally, in neurodegenerative disease processes. We will first assess ependymal cells by sequencing cell suspensions from post-mortem human brains (from patients with and without MS) and analyzing their transcriptomic profiles. In a second set of investigations, we will examine the implications of disrupting ependymal cell function on wider brain health using a novel transgenic animal model. Altogether, this work will further our understanding of ependymal cells and clarify their contribution(s) to neurodegenerative disease mechanisms and the pathophysiology of MS. With continued insights into ependymal cell biology, these cells represent key targets for future pharmacological intervention.
Department
Program
Doctoral: Vanier Canada Graduate Scholarships
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
457467
Name
Groh Adam M
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Vanier Canada Graduate Scholarships CIHR
Projecttitle
Unveiling the Unique Transcriptomic Landscape of Ependymal Cells in Multiple Sclerosis and Neurodegeneration: A Multimodal Study of Cerebrospinal Fluid Dynamics and Periventricular Inflammation
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
Doctoral: Vanier Canada Graduate Scholarships
Keyworddelim
Animal Model; Cerebral Ventricle; Cerebrospinal Fluid; Ependymal Cell; Hydrocephalus; Magnetic Resonance Imaging; Multiple Sclerosis; Neuroimmunology; Neuroinflammation; Single Nuclear Transcriptomics
Abstract
The brain is a complex organ composed of two primary cell types: neurons and glia. Neurons communicate through interfaces called synapses, which allow us to think, feel, and act. Glia are the true workhorses of the brain that support neurons in a variety of roles. The ependymal cell is a unique glial cell that, until recently, has been critically understudied. Ependymal cells line a set of cavities in the center of the brain called ventricles, which contain cerebrospinal fluid (CSF). Recent evidence suggests that ependymal cells are critical in maintaining circulation of CSF and mediating the exchange of nutrients/waste between CSF and surrounding brain tissue. Further, ependymal cell disruption leads to widespread brain degeneration and alterations in the flow of CSF. Interestingly, these patterns of brain dysregulation are strikingly similar to those in the brains of patients with multiple sclerosis (MS), a neurological disease in which aberrant immune cells initiate widespread inflammation in the brain. Despite these similarities, we still do not understand how ependymal cells become damaged or how these alterations might contribute to brain dysfunction in MS. Our lab will use two distinct methods to assess the role of ependymal cells both directly in MS, and more generally, in neurodegenerative disease processes. We will first assess ependymal cells by sequencing cell suspensions from post-mortem human brains (from patients with and without MS) and analyzing their transcriptomic profiles. In a second set of investigations, we will examine the implications of disrupting ependymal cell function on wider brain health using a novel transgenic animal model. Altogether, this work will further our understanding of ependymal cells and clarify their contribution(s) to neurodegenerative disease mechanisms and the pathophysiology of MS. With continued insights into ependymal cell biology, these cells represent key targets for future pharmacological intervention.
Competitiondate
202111
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Groh, Adam M
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~